ALNY NASDAQ
Alnylam Pharmaceuticals, Inc.
1W: +2.4%
1M: -3.2%
3M: -10.6%
YTD: -24.9%
1Y: +3.0%
3Y: +57.4%
5Y: +121.5%
$297.45
-3.06 (-1.02%)
Weekly Expected Move ±4.3%
$262
$275
$287
$299
$312
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$4B
Revenue
+82.6% YoY
$577M
Net Income
+314.0% YoY
$641M
Free Cash Flow
+950.8% YoY
81.9%
Gross Margin
23.0%
Op. Margin
17.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE134.8%
ROA12.5%
ROIC-92.8%
Valuation
P/E68.5
P/B36.8
EV/EBITDA71.9
Leverage
Debt/Equity1.62
Current Ratio2.76
Interest Cov.2.0x
Quality Scores
Piotroski F6/9
Altman Z6.55
Beneish M-1.75